Organogenesis Holdings Stock Market Value
| ORGO Stock | USD 3.68 0.01 0.27% |
| Symbol | Organogenesis |
Organogenesis Holdings Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.5 | Earnings Share (0.05) | Revenue Per Share | Quarterly Revenue Growth 0.061 | Return On Assets |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Organogenesis Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Organogenesis Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Organogenesis Holdings.
| 02/07/2024 |
| 02/01/2025 |
If you would invest 0.00 in Organogenesis Holdings on February 7, 2024 and sell it all today you would earn a total of 0.00 from holding Organogenesis Holdings or generate 0.0% return on investment in Organogenesis Holdings over 360 days. Organogenesis Holdings is related to or competes with Shuttle Pharmaceuticals, Lifecore Biomedical, Redhill Biopharma, Collegium Pharmaceutical, Alpha Teknova, Petros Pharmaceuticals, and Alkermes Plc. Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for th... More
Organogenesis Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Organogenesis Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Organogenesis Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.87 | |||
| Information Ratio | 0.0841 | |||
| Maximum Drawdown | 37.89 | |||
| Value At Risk | (5.31) | |||
| Potential Upside | 6.74 |
Organogenesis Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Organogenesis Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Organogenesis Holdings' standard deviation. In reality, there are many statistical measures that can use Organogenesis Holdings historical prices to predict the future Organogenesis Holdings' volatility.| Risk Adjusted Performance | 0.0946 | |||
| Jensen Alpha | 0.4657 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.1136 | |||
| Treynor Ratio | 0.7475 |
Organogenesis Holdings Backtested Returns
Organogenesis Holdings appears to be risky, given 3 months investment horizon. Organogenesis Holdings maintains Sharpe Ratio (i.e., Efficiency) of 0.0887, which implies the firm had a 0.0887 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Organogenesis Holdings, which you can use to evaluate the volatility of the company. Please evaluate Organogenesis Holdings' Semi Deviation of 3.56, risk adjusted performance of 0.0946, and Coefficient Of Variation of 969.04 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Organogenesis Holdings holds a performance score of 6. The company holds a Beta of 0.71, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Organogenesis Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding Organogenesis Holdings is expected to be smaller as well. Please check Organogenesis Holdings' downside variance, and the relationship between the sortino ratio and daily balance of power , to make a quick decision on whether Organogenesis Holdings' historical price patterns will revert.
Auto-correlation | -0.41 |
Modest reverse predictability
Organogenesis Holdings has modest reverse predictability. Overlapping area represents the amount of predictability between Organogenesis Holdings time series from 7th of February 2024 to 5th of August 2024 and 5th of August 2024 to 1st of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Organogenesis Holdings price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Organogenesis Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.41 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.2 |
Organogenesis Holdings lagged returns against current returns
Autocorrelation, which is Organogenesis Holdings stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Organogenesis Holdings' stock expected returns. We can calculate the autocorrelation of Organogenesis Holdings returns to help us make a trade decision. For example, suppose you find that Organogenesis Holdings has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Organogenesis Holdings regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Organogenesis Holdings stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Organogenesis Holdings stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Organogenesis Holdings stock over time.
Current vs Lagged Prices |
| Timeline |
Organogenesis Holdings Lagged Returns
When evaluating Organogenesis Holdings' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Organogenesis Holdings stock have on its future price. Organogenesis Holdings autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Organogenesis Holdings autocorrelation shows the relationship between Organogenesis Holdings stock current value and its past values and can show if there is a momentum factor associated with investing in Organogenesis Holdings.
Regressed Prices |
| Timeline |
Pair Trading with Organogenesis Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organogenesis Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will appreciate offsetting losses from the drop in the long position's value.Moving together with Organogenesis Stock
| 0.67 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
Moving against Organogenesis Stock
| 0.66 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.61 | PTPI | Petros Pharmaceuticals | PairCorr |
| 0.53 | ABBV | AbbVie Inc Buyout Trend | PairCorr |
| 0.48 | CPHI | China Pharma Holdings | PairCorr |
| 0.44 | BFRI | Biofrontera | PairCorr |
The ability to find closely correlated positions to Organogenesis Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organogenesis Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organogenesis Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organogenesis Holdings to buy it.
The correlation of Organogenesis Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organogenesis Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organogenesis Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organogenesis Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Organogenesis Holdings Correlation, Organogenesis Holdings Volatility and Organogenesis Holdings Alpha and Beta module to complement your research on Organogenesis Holdings. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Organogenesis Holdings technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.